New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines
Low efficiency of chemotherapy in ovarian cancer results from the development of drug resistance. Cisplatin (CIS) and topotecan (TOP) are drugs used in chemotherapy of this cancer. We analyzed the development of CIS and TOP resistance in ovarian cancer cell lines. Incubation of drug sensitive cell l...
Main Authors: | Monika Świerczewska, Andrzej Klejewski, Karolina Wojtowicz, Maciej Brązert, Dariusz Iżycki, Michał Nowicki, Maciej Zabel, Radosław Januchowski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/22/10/1717 |
Similar Items
-
New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines
by: Monika Świerczewska, et al.
Published: (2018-04-01) -
Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer
by: Piotr J. Wysocki, et al.
Published: (2023-02-01) -
The role of topotecan in prolongation of platinum-free interval in patients with recurrent ovarian cancer
by: E U Moskovskaya, et al.
Published: (2014-03-01) -
Piperine Targets Different Drug Resistance Mechanisms in Human Ovarian Cancer Cell Lines Leading to Increased Sensitivity to Cytotoxic Drugs
by: Karolina Wojtowicz, et al.
Published: (2021-04-01) -
Therapeutic uses of topotecan for thoracic malignancies
by: Saoirse O. Dolly, et al.
Published: (2011-12-01)